Search results - 26 articles

Categories: Articles in English, Life Sciences, Strategy

Many emerging markets have already recognized the potential of biotechnology to transform health care delivery. Can the developed world keep up with the pace of innovation?

Publication date: 2012-02

Categories: Articles in English, Governance & Risk, Government & Public Sector, Life Sciences, Organization & People, Processes

When an outbreak of swine flu put pressure on the UK’s health care system, Ernst & Young helped NHS Direct develop and deliver a highly effective pandemic flu response service to meet one of the greatest challenges to the UK health system. It has since become a model of best practice.

Publication date: 2012-02

Choosing the right technology: a framework for success

Categories: Articles in English, Automotive, Consumer Products, Life Sciences, Organization & People, Processes, Strategy, Telecommunications

In this article, we consider a framework to help companies make informed decisions about their technology development. The framework identifies the levels of innovation, the competing technologies at each level, the dimensions of performance on which to compare them and the patterns of evolution on each dimension.

Publication date: 2011-05

Supply chain transformation: a blueprint for success

Categories: Articles in English, Consumer Products, Life Sciences, Organization & People, Processes

A case study examining how we helped Fresenius Medical Care EMEALA transform its supply chain operations, enabling it to make cash savings of 15 million euros from the reduction in stock holding and laying the foundations for future growth.

Publication date: 2011-05

Competing for market share in rural India

Categories: Articles in English, Automotive, Cleantech, Consumer Products, Life Sciences, Organization & People, Processes, Strategy

This article discusses how the project team assisted a manufacturing company to improve its market share performance by focusing on growth opportunities in semi-urban and rural markets in India. It highlights an approach which has successfully enhanced market share performance and could be adopted by other product-based businesses.

Publication date: 2011-05

Erfolgsfaktoren von Spin-offs aus Forschungseinrichtungen

Categories: Articles in German, Life Sciences, Strategy, Technology, Transaction

Ausgründungen (Spin-offs) aus Forschungseinrichtungen verfügen meist über einzigartige Start- und Entwicklungsbedingungen, da sie als technologieorientierte Unternehmensgründungen auf Methoden und Know-how ihrer Mutterinstitute zurückgreifen können und umfangreiche Unterstützungsleistungen erhalten. Die Bewertung des Erfolgs dieser Ausgründungen ist jedoch ein komplexes Unterfangen. Dieser Artikel analysiert die Wege, mit denen sich der Erfolg messen lässt.

Publication date: 2009-07

Pharmaindustrie: Auf dem Weg zu neuen Geschäftsmodellen

Categories: Articles in German, Life Sciences, Processes, Strategy

Die Unternehmen Pharmaindustrie stehen vor großen Herausforderungen: Sie müssen sich an ein stark verändertes Marktumfeld anpassen. Entscheidend für den Geschäfterfolg eines Pharmaunternehmens ist nicht mehr nur die Produktpipeline, sondern das gesamte Geschäftsmodell. Wir haben elf Funktionen definiert, die den Transformationsprozess unterstützen. Der Artikel erläutert diese Funktionen.

Publication date: 2009-07

Hidden costs of outsourcing

Categories: Articles in English, Life Sciences, Processes, Strategy

Outsourcing has become the order of the day for companies seeking lower their operating costs. The article, while admitting the cost benefits of outsourcing, highlights the possible risks associated with outsourcing and suggests an alternative solution.

Publication date: 2008-05

Page 3 of 3123
EY refers to one or more of the member firms of Ernst & Young Global Limited (EYG), a UK private company limited by guarantee. EYG is the principal governance entity of the global EY organization and does not provide any service to clients. Services are provided by EYG member firms. Each of EYG and its member firms is a separate legal entity and has no liability for another such entity's acts or omissions. Certain content on this site may have been prepared by one or more EYG member firms